231 related articles for article (PubMed ID: 35626252)
1. Can We Use Urinary Cytokine/Chemokine Analysis in Discriminating Ulcer-Type Interstitial Cystitis/Bladder Pain Syndrome?
Jiang YH; Jhang JF; Kuo HC
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626252
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Hsu YH; Kuo HC
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233356
[TBL] [Abstract][Full Text] [Related]
3. Use of Urinary Cytokine and Chemokine Levels for Identifying Bladder Conditions and Predicting Treatment Outcomes in Patients with Interstitial Cystitis/Bladder Pain Syndrome.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625885
[TBL] [Abstract][Full Text] [Related]
4. Urine cytokines as biomarkers for diagnosing interstitial cystitis/bladder pain syndrome and mapping its clinical characteristics.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1391-F1399. PubMed ID: 32281420
[TBL] [Abstract][Full Text] [Related]
5. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
[TBL] [Abstract][Full Text] [Related]
6. Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome.
Jiang YH; Jhang JF; Ho HC; Chiou DY; Kuo HC
Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35885006
[TBL] [Abstract][Full Text] [Related]
7. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
8. Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment.
Yu WR; Jhang JF; Ho HC; Jiang YH; Lee CL; Hsu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):455. PubMed ID: 33432045
[TBL] [Abstract][Full Text] [Related]
9. Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm.
Jiang YH; Jhang JF; Hsu YH; Ho HC; Wu YH; Kuo HC
Sci Rep; 2021 Jan; 11(1):914. PubMed ID: 33441752
[TBL] [Abstract][Full Text] [Related]
10. Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.
Jiang YH; Peng CH; Liu HT; Kuo HC
PLoS One; 2013; 8(10):e76779. PubMed ID: 24146927
[TBL] [Abstract][Full Text] [Related]
11. Cystoscopic characteristic findings of interstitial cystitis and clinical implications.
Yu WR; Jiang YH; Jhang JF; Kuo HC
Tzu Chi Med J; 2024; 36(1):30-37. PubMed ID: 38406570
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder.
Furuta A; Yamamoto T; Suzuki Y; Gotoh M; Egawa S; Yoshimura N
Int Urogynecol J; 2018 Jul; 29(7):961-966. PubMed ID: 29372285
[TBL] [Abstract][Full Text] [Related]
13. Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis.
Wang L; Gao J; Zheng S; Wang Z; Zheng S; Luo Z
Arch Esp Urol; 2024 May; 77(4):353-358. PubMed ID: 38840277
[TBL] [Abstract][Full Text] [Related]
14. Combination of urinary biomarkers and machine-learning models provided a higher predictive accuracy to predict long-term treatment outcomes of patients with interstitial cystitis/bladder pain syndrome.
Jhang JF; Yu WR; Huang WT; Kuo HC
World J Urol; 2024 Mar; 42(1):173. PubMed ID: 38507059
[TBL] [Abstract][Full Text] [Related]
15. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
16. Urinary Oxidative Stress Biomarker Levels Might Be Useful in Identifying Functional Bladder Disorders in Women with Frequency and Urgency Syndrome.
Jiang YH; Jhang JF; Kuo HC
J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983336
[TBL] [Abstract][Full Text] [Related]
17. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome.
Ke H; Zhu L; Wang Q; Xu K
BMC Urol; 2023 Nov; 23(1):180. PubMed ID: 37940904
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic value of urinary CXCL10 as a biomarker for predicting Hunner type interstitial cystitis.
Niimi A; Igawa Y; Aizawa N; Honma T; Nomiya A; Akiyama Y; Kamei J; Fujimura T; Fukuhara H; Homma Y
Neurourol Urodyn; 2018 Mar; 37(3):1113-1119. PubMed ID: 29048741
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of bladder corticotropin-releasing hormone receptor in the pathogenesis of human interstitial cystitis/bladder pain syndrome.
Jhang JF; Birder LA; Jiang YH; Hsu YH; Ho HC; Kuo HC
Sci Rep; 2019 Dec; 9(1):19169. PubMed ID: 31844086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
